| 17626 | AMOXIHEXAL 1000 TABS | tbl sol 12×1000mg | SFS | D |
| 17627 | AMOXIHEXAL 1000 TABS | tbl sol 24×1000mg | SFS | D |
| 17633 | AMOXIHEXAL 750 TABS | tbl sol 12×750mg | SFS | D |
| 17634 | AMOXIHEXAL 750 TABS | tbl sol 24×750mg | SFS | D |
| 44333 | AMOXIHEXAL 750 TABS | tbl sol 12×750mg | HHC | D |
| 44334 | AMOXIHEXAL 750 TABS | tbl sol 24×750mg | HHC | D |
| 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12×1000mg | HHC | D |
| 44336 | AMOXIHEXAL 1000 TABS | tbl sol 24×1000mg | HHC | D |
| 126.7 | J01CA06 | bakampicilin | p.o. | 1.20 | GM | 16,24 | ||
| 127 | peniciliny se širokým spektrem, ostatní cesty aplikace | |||||||
|---|---|---|---|---|---|---|---|---|
| 127.1 | J01CA01 | ampicilin | parent. | 2.00 | GM | 42,76 | K | |
| 86197 | AMPICILIN 0.5 BIOTIKA | inj sic 50×500mg | BTA | SK |
| 127.2 | J01CA09 | azlocilin | parent. | 12.00 | GM | 623,01 | U/ATB |
| 127.3 | J01CA12 | piperacilin | parent. | 14.00 | GM | 1 268,52 | U/ATB |
| 127.4 | J01CA13 | tikarcilin | parent. | 15.00 | GM | 1 935,95 | U/ATB |
| 127.5 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2.00 | GM | 142,64 | U/ATB |
| 127.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1.00 | GM | 95.22 | U/ATB |
| 127.7 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15.00 | GM | 1 519.94 | U/ATB |
| 93170 | TIMENTIN 3.2 GM | inj sic 4×3.2gm | SKW | GB |
| 127.8 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14.00 | GM | 1 636.92 | U/ATB |
| 127.9 | J01CR50 | kombinace penicilinů | parent. | 3.00 | DF | 70,17 | U |
| 128 | peniciliny citlivé k betalaktamáze, perorální podání | |||||||
|---|---|---|---|---|---|---|---|---|
| 128.1 | J01CE02 | fenoxymethylpenicilin ( od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2.00 | GM | 16,62 | ||
| 45996 | OSPEN 500 | por tbl flm 30×500ku | SZK | A |
| 92435 | V-PENICILIN 0.8 MEGA BIOTIKA | por tbl nob 30×800ku | BTA | SK |
| 92806 | V-PENICILIN 500 MG SLOVAKOFARMA | tbl 30×500mg-blistr | ZEH | SK |
| 128.2 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2.00 | GM | 17.55 |
| 92434 | V-PENICILIN 0.4 MEGA BIOTIKA | por tbl nob30×400ku | BTA | SK |
| 92805 | V-PENICILIN 250 MG SLOVAKOFARMA | tbl 30×250mg-blistr | ZEH | SK |
| 128.3 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2.00 | GM | 14,66 |
| 01881 | PENBENE1 000 000 | tbl obd 21×1 mu | MCK | D |
| 05960 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 20×750mg-bli | ZEH | SK |
| 44708 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 30×750mg-bli | ZEH | SK |
| 45997 | OSPEN 1000 | por tbl flm 30×1000ku | SZK | A |
| 45998 | OSPEN 1500 | por tbl flm 30×1500ku | SZK | A |
| 49513 | PENBENE1 000 000 | tbl obd 30×1 mu | MCK | D |
| 57778 | PENBENE1 500 000 | tbl obd 21 | MCK | D |
| 65356 | PENBENE1 000 000 | tbl obd 12×1 mu | MCK | D |
| 66359 | OSPEN 1000 | por tbl flm 12×1000ku | SZK | A |
| 66360 | OSPEN 1500 | por tbl flm 12×1500ku | SZK | A |
| 92436 | V-PENICILIN 1.2 MEGA BIOTIKA | por tbl nob 30×1.2mu | BTA | SK |
| 128.4 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2.00 | GM | 68,40 | |
| 128.5 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2.00 | GM | 25,70 | |
| 128.6 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 13,87 | |
| 56442 | PENCLEN | tbl 30×350mg-bli | ZEH | SK |
| 128.7 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2.00 | GM | 17,47 |
| 49549 | OSPEN 400 | sir 1×150ml | SZK | A |
| 76213 | OSPEN 750 KRKA | por sus 1×60ml/9gm | KRK | SLO |
| 129 | peniciliny citlivé k betalaktamáze, ostatní cesty aplikace | |||||||
|---|---|---|---|---|---|---|---|---|
| 129.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.60 | GM | 118,54 | K | |
| 01093 | PENICILIN G 1.0 DRAS.SOL BIOT. | inj sic 10×1 mu | BTA | SK |
| 129.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.60 | GM | 47,95 | K |
| 93405 | PENICILIN G 5.0 DRAS.SOL BIOT. | inj sic 10×5mu | BTA | SK |
| 129.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2.00 | MU | 69,03 | K |
| 129.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2.00 | MU | 25,11 | K |
| 01764 | RETARPEN 2.4 M.U.I. | inj sic 50×2.4mu | SZK | A |
| 129.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2.00 | MU | 77,77 | K |
| 129.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2.00 | MU | 38,67 | K |
| 01102 | PROKAIN PENICILIN G 1.5 BIOTIKA | inj sic 10×1.5mu | BTA | SK |
| 129.7 | J01CE30 | kombinace | parent. | 0.50 | DF | 10,08 | K |
| 02723 | PENDEPON COMPOSITUM | inj sic 10×1.5mu | BTA | SK |
| 130 | peniciliny rezistentní k betalaktamáze a kombinace penicilinů včetně inhibitorů betalaktamáz, perorální podání | |||||
|---|---|---|---|---|---|---|
| 130.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2.00 | GM | 30.57 |
| 130.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2.00 | GM | 39,07 |
| 130.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2.00 | GM | 30.57 |
| 130.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2.00 | GM | 39,07 |
| 130.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1.00 | GM | 25,20 |
| 130.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 1 g v 1 tabletě) | p.o. | 1.00 | GM | 16,32 |
| 130.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1.00 | GM | 22,97 |
| 130.8 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg do 1 g v 1 tabletě včetně) | p.o. | 1.00 | GM | 21,55 |
| 130.9 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1.00 | GM | 33,09 |
| 130.10 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1.00 | GM | 25,06 |
| 44793 | AUGMENTIN DUO | por piv sus 1×140ml | SKW | GB |
| 84792 | AUGMENTIN DUO | por piv sus 1×70ml | SKW | GB |
| 130.11 J01CR04 | sultamicilin (pevné lékové formy) | p.o. | 1.50 | GM 64,49 |
| 17149 | UNASYN | por tbl flm 12×375mg | PFI | I |
| 72881 | UNASYN | tbl obd 12×375mg | PFI | TR |
| 130.12 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.50 | GM | 67,59 |
| 131 | jiná betalaktamová antibiotika, perorální podání | |||||||
|---|---|---|---|---|---|---|---|---|
| 131.1 | J01DB01 | cefalexin (pevné lékové formy) | p.o. | 2.00 | GM | 29,36 | ||
| 66357 | OSPEXIN 1000MG | tbl obd 12×1000mg | SZK | A |
| 131.2 | J01DB01 | cefalexin (tekuté lékové formy) | p.o. | 2.00 | GM | 38,63 |
| 66354 | OSPEXIN 250MG/5ML | gra sus 1×60ml | SZK | A |
| 66355 | OSPEXIN 375MG/5ML | gra sus 1×60ml | SZK | A |
| 131.3 | J01DC02 | cefuroxim axetil (pevné lékové formy) | p.o. | 1.00 | GM | 85,74 |
| 18499 | XORIMAX 125 MG POTAH.TABLETY | por tbl flm 10×125mg | SZK | A |
| 18523 | XORIMAX250 MG POTAH.TABLETY | por tbl flm 10×250mg | SZK | A |
| 18547 | XORIMAX500 MG POTAH.TABLETY | por tbl flm 10×500mg | SZK | A |
| 131.4 | J01DC02 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1.00 | GM | 131,64 | |
| 131.5 | J01DC04 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.50 | GM | 56,15 | |
| 16450 | VERCEF 250 MG | cps 3×7=21 bii | IRI | IRL |
| 53153 | VERCEF 250MG | cps 7×3(blistr) | RDD | IND |
| 131.6 | J01DC04 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.50 | GM | 52,58 | |
| 131.7 | J01DC04 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.50 | GM | 82,09 | |
| 131.8 | J01DC04 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.50 | GM | 68,61 | |
| 131.9 | J01DB05 | cefadroxil (pevné lékové formy) | p.o. | 2.00 | GM | 29,36 | |
| 131.10 | J01DB05 | cefadroxil (tekuté lékové formy) | p.o. | 2.00 | GM | 39,99 | |
| 131.11 | J01DD08 | cefixim | p.o. | 0.40 | GM | 88,93 | ATB |
| 131.12 | J01DD10 | cefetamet | p.o. | 1.00 | GM | 88,93 | ATB |
| 131.13 | J01DD13 | cefpodoxim | p.o. | 0.40 | GM | 85,74 | ATB |
| 131.14 | J01DD14 | ceftibuten | p.o. | 0.40 | GM | 85,74 | ATB |
| 131.15 | J01DC10 | cefprozil (pevné lékové formy) | p.o. | 1.00 | GM | 85,74 | |
| 131.16 | J01DC10 | cefprozil (tekuté lékové formy) | p.o. | 1.00 | GM | 131,64 | |
| 132 | jiná betalaktamová antibiotika, ostatní cesty aplikace | |||||||
|---|---|---|---|---|---|---|---|---|
| 132.1 | J01CF04 | oxacilin | parent. | 2.00 | GM | 93,63 | K | |
| 132.2 | J01DD62 | cefoperazon a inhibitor beta-laktamázy | parent. | 2.00 | GM | 387,99 | U/ATB | |
| 132.3 | J01DB03 | cefalotin | parent. | 4.00 | GM | 120.61 | U/ATB | |
| 132.4 | J01DB04 | cefazolin | parent. | 3.00 | GM | 111,41 | U/ATB | |
| 02205 | CEFAZOLINE PANPHARMA | inj sic 25×1 gm | LPA | F |
| 84018 | CEFAZOLINE PANPHARMA | inj sic 50×1 gm | LPA | F |
| 132.5 | J01DC01 | cefoxitin | parent. | 6.00 | GM | 916,50 | U/ATB |
| 132.6 | J01DC02 | cefuroxim | parent. | 4.00 | GM | 270,25 | U/ATB |
| 64831 | AXETINE 1.5GM | inj sic 10×1.5gm | MOE | CY |
| 64833 | AXETINE 1.5GM | inj sic 100×1.5gm | MOE | CY |
| 64835 | AXETINE 750 MG | inj sic 10×750mg | MOE | CY |
| 64837 | AXETINE 750 MG | inj sic 100×750mg | MOE | CY |
| 132.7 | J01DC04 | cefamandol | parent. | 6.00 | GM | 562,21 | U/ATB |
| 132.8 | J01DD01 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6.00 | GM | 397,83 | U/ATB |
| 15669 | CEFTAX 1000 | inj sic 1×1000mg | HIK | P |
| 49193 | CEFTAX 1000 | inj plv sol 10×1000mg | HIK | P |
| 83050 | SEFOTAK1G | inj piv sol 1×1 gm | ICZ | CZ |
| 132.9 | J01DD01 | cefotaxim nad 1 g v jedné ampuli | parent. | 6.00 | GM | 430,56 | U/ATB |
| 132.10 | J01DD02 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6.00 | GM | 1 696,77 | U/ATB |
| 132.11 | J01DD02 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6.00 | GM | 1 641,30 | U/ATB |
| 76353 | FORTUM 1 G | inj piv sol 1×1 gm | GWE | I |
| 76354 | FORTUM 2 G | inj piv sol 1×2gm | GWE | I |
| 132.12 | J01DD03 | cefsulodin | parent. | 6.00 | GM | 601,70 | U/ATB |
| 132.13 | J01DD04 | ceftriaxon | parent. | 2.00 | GM | 471,31 | ambulantně: K/P ústavně: U/ATB |
Ceftriaxon v ambulantní péči předepisuje neurolog, infekcionista, dermatolog, pediatr nebo revmatolog k:
- a) léčbě Lymské boreliózy II. a III. stádium (doložené laboratorním vyšetřením),
- b) léčbě nekomplikované akutní kapavky (jednorázová nitrosvalová aplikace 250 mg ceftriaxonu).
- c) v druhé volbě léčby syfilis po vyčerpání možností standardní léčby penicilinem
| 58756 | CEFTRIAXON TORREX 2 G | inj piv sol 1×2gm | TRX | A |
| 132.14 | J01DD07 | ceftizoxim | parent. | 4.00 | GM | 601,70 | U/ATB |
| 132.15 | J01DE01 | cefepim | parent. | 4.00 | GM | 1 412,20 | U/ATB |
| 132.16 | J01DB08 | cefapirin | parent. | 4.00 | GM | 190,31 | U/ATB |
| 132.17 | J01DD12 | cefoperazon | parent. | 6.00 | GM | 1 267,56 | U/ATB |
| 132.18 | J01DE02 | cefpirom | parent. | 4.00 | GM | 1 601,21 | U/ATB |
| 132.19 | J01DF01 | aztreonam | parent. | 4.00 | GM | 1 608,24 | U/ATB |
| 132.20 | J01DH03 | ertapenem | parent. | 1.00 | GM | 1 603,36 | U/ATB |
| 132.21 | J01DH02 | meropenem | parent. | 2.00 | GM | 1 946,10 | U/ATB |
| 132.22 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2.00 | GM | 2 118,56 | U/ATB |
| 133 | sulfonamidy a trimetoprim | |||||||
|---|---|---|---|---|---|---|---|---|
| 133.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.40 | GM | 10,76 | ||
| 89812 | TRIPRIM 100MG | tbl 10×100mg | MCK | D |
| 89813 | TRIPRIM 100MG | tbl 20×100mg | MCK | D |
| 133.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.40 | GM | 8,25 |
| 89815 | TRIPRIM 200MG | tbl 10×200mg | MCK | D |
| 89816 | TRIPRIM 200MG | tbl 20×200mg | MCK | D |
| 133.3 | J01EB05 | sulfafurazol | p.o. | 4.00 | GM | 13,33 | |
| 133.4 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 124,16 | K |
| 133.5 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6,25 | |
| 75022 | COTRIMOXAZOL AL FORTE | tbl 10×960mg | APA | D |
| 75023 | COTRIMOXAZOL AL FORTE | tbl 20×960mg | APA | D |
| 133.6 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 16,67 | |
| 133.7 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 21,88 | |
| 133.8 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,78 | |
| 133.9 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,55 | |
| 133.10 | J01EE04 | sulfamoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,78 | |
| 133.11 | J01EE04 | sulfamoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,55 | |
| 133.12 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,78 | |
| 134 | makrolidová antibiotika a jejich kombinace s antibakteriálními léčivy | |||||||
|---|---|---|---|---|---|---|---|---|
| 134.1 | J01FA | telithromycin | p.o. | 800.00 | MG | 94,60 | U/ATB | |
| 134.2 | J01FA01 | erythromycin | parent. | 1.00 | GM | 701,21 | K | |
| 134.3 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1.00 | GM | 18,66 | ||
| 134.4 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1.00 | GM | 32,93 | ||
| 55585 | MEROMYCIN | piv sus 1×100ml | MCK | D |
| 134.5 | J01FA02 | spiramycin | p.o. | 3.00 | GM | 41,78 | |
| 134.6 | J01FA02 | spiramycin | parent. | 4.50 | MU | 612,82 | K |
| 17129 | ROVAMYCINE PLV.PRO INF.1.5MIU | piv inf 1×1.5mu | AVM | F |
| 134.7 | J01FA05 | oleandomycin | p.o. | 1.00 | GM | 14,26 | |
| 134.8 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.30 | GM | 37,79 | |
| 134.9 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.30 | GM | 30,88 | |
| 10855 | ROXITHROMYCIN-RATIOPHARM 150 MG | por tbl flm 10×150mg | MCK | D |
| 10857 | ROXITHROMYCIN-RATIOPHARM 150 MG | por tbl flm 14×150mg | MCK | D |
| 10875 | ROXITH ROMYCI N-RATI OPHARM 300 MG | por tbl flm 10×300mg | MCK | D |
| 134.10 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2.00 | GM | 29,40 | |
| 134.11 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1.00 | GM | 39,53 | |
| 134.12 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.50 | GM | 31,66 | |
| 134.13 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.50 | GM | 52,64 | |
| 134.14 | J01FA09 | klaritromycin | parent. | 1.00 | GM | 643,67 | K |
| 134.15 | J01FA10 | azithromycin (pevné lékové formy) | p.o. | 0.30 | GM | 49,26 | |
| 134.16 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.30 | GM | 87,73 | |
| 134.17 | J01FA10 | azitromycin | parent. | 0.50 | GM | 406,85 | K |
| 134.18 | J01FA13 | dirythromycin | p.o. | 0.50 | GM | 41,78 | |
| 134.19 | J01FG02 | quinupristin v kombinaci s dalfopristinem | parent | 1.00 | DF | 2 364,70 | U/ATB |
| 134.20 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5.00 | DF | 31,43 | |
| 135 | linkosamidová antibiotika | |||||||
|---|---|---|---|---|---|---|---|---|
| 135.1 | J01FF01 | klindamycin (do 0,3 gm včetně v jedné ampuli) | parent. | 1.80 | GM | 447,51 | U/ATB | |
| 135.2 | J01FF01 | klindamycin (nad 0,3 gm v jedné ampuli) | parent. | 1.80 | GM | 406,53 | U/ATB | |
| 135.3 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.20 | GM | 41,19 | ||
| 135.4 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.20 | GM | 126,76 | ||
| 135.5 | J01FF02 | linkomycin | parent. | 1.80 | GM | 48,05 | U/ATB | |
| 135.6 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.80 | GM | 29,56 | ATB | |
| 91997 | NELOREN | cps 16×500mg | LEK | SLO |
| 135.7 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.80 | GM | 156,97 | ATB |
| 136 | aminoglykosidová antibiotika | ||||||
|---|---|---|---|---|---|---|---|
| 136.1 | J01GA01 | streptomycin | parent. | 1.00 | GM | 90,82 | |
| 13797 | STREPTOMYCIN 1GM | piv sol 10×1gm/lahv | BAK | BG |
| 136.2 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 42,84 | U/ATB |
| 136.3 | J01GB01 | tobramycin (léková forma - inhalační roztok) | inhal. | 0.60 | GM | 2 497,50 | P |
Tobramycin v inhalační formě je indikován u pacientů s cystickou fibrózou infikovaných Pseudomonas aeruginosa, starších 6-ti let.
| 136.4 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 22,50 | U/ATB |
| 136.5 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 44,15 | U/ATB |
| 136.6 | J01GB03 | gentamicin (lékové formy kuliček k implantaci) | imp. | 1.00 | DF | 148,61 | U/ATB |
| 136.7 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130.00 | MG | 2 290,74 | U/ATB |
| 136.8 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,07 | U/ATB |
| 136.9 | J01GB05 | neomycin | parent. | 1.00 | GM | 119,56 | U/ATB |
| 136.10 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1.00 | GM | 651,76 | U/ATB |
| 136.11 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1.00 | GM | 350,66 | U/ATB |
| 136.12 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 508,13 | U/ATB |
| 136.13 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 297,66 | U/ATB |
| 136.14 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1.00 | GM | 606,19 | U/ATB |
| 136.15 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1.00 | GM | 505,17 | U/ATB |
| 137 | chinolonová chemoterapeutika | |||||||
|---|---|---|---|---|---|---|---|---|
| 137.1 | J01MA | trovafloxacin | p.o. | 0.20 | GM | 23,94 | ATB | |
K léčbě trovafloxacinem je třeba konzultace a schválení antibiotického střediska.
| 137.2 | J01MA | trovafloxacin | parent. | 0.20 | GM | 207,41 | U/ATB |
| 137.3 | J01MA01 | ofloxacin | p.o. | 0.40 | GM | 16.14 | |
| 137.4 | J01MA01 | ofloxacin | parent. | 0.40 | GM | 207,41 | U/ATB |
| 137.5 | J01MA02 | ciprofloxacin | p.o. | 1.00 | GM | 16.14 | |
| 15653 | CIPLOX250 | tbl obd 10×250mg | SDD | CZ |
| 15654 | CIPLOX250 | tbl obd 50×250mg | SDD | CZ |
| 15658 | CIPLOX500 | tbl obd 10×500mg | SDD | CZ |
| 15659 | CIPLOX500 | tbl obd 50×500mg | SDD | CZ |
| 44985 | CIPLOX500 | tbl obd 10×500mg | CIA | IND |
| 44986 | CIPLOX500 | tbl obd 50×500mg | CIA | IND |
| 44988 | CIPLOX250 | tbl obd 10×250mg | CIA | IND |
| 44989 | CIPLOX250 | tbl obd 50×250mg | CIA | IND |
| 94453 | CIPRINOL250 | tbl obd 10×250mg | KRK | SLO |
| 96039 | CIPRINOL500 | tbl obd 10×500mg | KRK | SLO |
| 137.6 | J01MA02 | ciprofloxacin – infúze | parent. | 0.50 | GM | 207,41 | U/ATB |
| 15651 | CIPLOX | inf 1×100ml(plast) | SDD | CZ |
| 56830 | CIPLOX | inf 1×100ml(plast) | CIA | IND |
| 59830 | CIPRINOL200MG/100ML | inf 1×100ml/200mg | KRK | SLO |
| 137.7 | J01MA02 | ciprofloxacin - injekce | parent. | 0.50 | GM | 182,60 | U/ATB |
| 96040 | CIPRINOL100MG/10ML | inf 5×10m 1/100mg | KRK | SLO |
| 137.8 | J01MA03 | pefloxacin | p.o. | 0.80 | GM | 16.14 | |
| 137.9 | J01MA03 | pefloxacin | parent. | 0.80 | GM | 91,14 | U/ATB |
| 137.10 | J01MA04 | enoxacin | p.o. | 0.80 | GM | 16,14 | |
| 137.11 | J01MA06 | norfloxacin | p.o. | 0.80 | GM | 16,14 | |
| 01660 | NORFLOXACIN-RATIOPHARM 400MG | por tbl flm 20×400mg | MCK | D |
| 42549 | NORFLOXACIN-RATIOPHARM 400MG | por tbl flm 14×400mg | MCK | D |
| 44090 | GYRABLOCK 400 | por tbl flm 500×400mg | MOE | CY |
| 44091 | GYRABLOCK 400 | por tbl flm 1000×400mg | MOE | CY |
| 93465 | NOLICIN | tbl obd 20×400mg | KRK | SLO |
| 137.12 | J01MA07 | lomefloxacin | p.o. | 0.80 | GM | 16,14 | |
| 137.13 | J01MA08 | fleroxacin | p.o. | 0.40 | GM | 16,14 | |
| 137.14 | J01MA08 | fleroxacin | parent. | 0.40 | GM | 207,41 | U/ATB |
| 137.15 | J01MA09 | sparfloxacin | p.o. | 0.20 | GM | 16,14 | ATB |
K léčbě sparfloxacinem je třeba konzultace a schválení antibiotického střediska.
| 137.16 | J01MA12 | levofloxacin | parent | 0.25 | GM | 207,31 | U/ATB |
| 137.17 | J01MA12 | levofloxacin do 250 mg v jedné tabletě včetně | p.o. | 0.25 | GM | 73,30 | U/ATB |
| 137.18 | J01MA12 | levofloxacin nad 250 mg v jedné tabletě | p.o. | 0.25 | GM | 58,64 | U/ATB |
| 137.19 | J01MA14 | moxifloxacin | p.o. | 0.40 | GM | 58,64 | U/ATB |
| 138 | ostatní antibiotika či chemoterapeutika, včetně močových chemoterapeutik | |||||||
|---|---|---|---|---|---|---|---|---|
| 138.1 | J01XA01 | vankomycin | parent. | 2.00 | GM | 1 266.40 | U/ATB | |
| 138.2 | J01XA02 | teikoplanin | parent. | 0.40 | GM | 2 135.02 | U/ATB | |
| 138.3 | J01XB01 | kolistin | p.o. | 3.00 | MU | 41,85 | U/ATB | |
| 138.4 | J01XB01 | kolistin | parent. | 3.00 | MU | 106,86 | U/ATB | |
| 138.5 | J01XB02 | polymyxin | parent. | 0.15 | GM | 100,75 | U/ATB | |
| 138.6 | J01XX08 | linezolid | p.o. | 1.20 | GM | 4 019.08 | U/ATB | |
| 03902 | ZYVOXID | por tbl flm10×600mg | PMB | B |
| 138.7 | J01XX08 | linezolid | parent | 1.20 | GM | 3 964.11 | U/ATB |
| 03708 | ZYVOXID | inf sol 10×300ml | FRK | N |
| 139 | imidazolová chemoteraputika pro celkové použití a jiné antibakteriální látky | |||||||
|---|---|---|---|---|---|---|---|---|
| 139.1 | G01AX05 | nifuratel | p.o. | 0.60 | GM | 12,22 | ||
| 139.2 | J01XD01 | metronidazol | p.o. | 2.00 | GM | 12,68 | ||
| 02427 | ENTIZOL | tbl 20×250mg | ZPF | PL |